Home
>
National Drug Code (NDC)
>
Solaraze
Solaraze - 10337-803-08 - (diclofenac sodium)
Drug Information of Solaraze
| Product NDC: | 10337-803 |
| Proprietary Name: | Solaraze |
| Non Proprietary Name: | diclofenac sodium |
| Active Ingredient(s): | 30 mg/g & nbsp; diclofenac sodium |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Solaraze
| Product NDC: | 10337-803 |
| Labeler Name: | PharmaDerm, A division of Fougera Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021005 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001016 |
Package Information of Solaraze
| Package NDC: | 10337-803-08 |
| Package Description: | 2 g in 1 TUBE (10337-803-08) |
NDC Information of Solaraze
| NDC Code | 10337-803-08 |
| Proprietary Name | Solaraze |
| Package Description | 2 g in 1 TUBE (10337-803-08) |
| Product NDC | 10337-803 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | diclofenac sodium |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20001016 |
| Marketing Category Name | NDA |
| Labeler Name | PharmaDerm, A division of Fougera Pharmaceuticals Inc. |
| Substance Name | DICLOFENAC SODIUM |
| Strength Number | 30 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
